TY - JOUR
T1 - A chemical mutagenesis screen to identify modifier genes that interact with growth hormone and TGF-β signaling pathways
AU - Mohan, Subburaman
AU - Baylink, David J.
AU - Srivastava, Apurva K.
N1 - JavaScript is disabled on your browser. Please enable JavaScript to use all the features on this page. We describe a phenotype-driven mutagenesis screen in which mice carrying a targeted mutation are bred with ENU-treated males in order to provide a sensitized system for detecting dominant modifier mutations.
PY - 2008/2
Y1 - 2008/2
N2 - We describe a phenotype-driven mutagenesis screen in which mice carrying a targeted mutation are bred with ENU-treated males in order to provide a sensitized system for detecting dominant modifier mutations. The presence of initial mutation renders the screening system more responsive to subtle changes in modifier genes that would not be penetrant in an otherwise wild type background. We utilized two mutant mouse models: 1) mice carrying a mutation in growth hormone releasing hormone receptor (Ghrhr) (denoted 'lit' allele, Ghrhrlit), which results in GH deficiency; and 2) mice lacking Smad2 gene, a signal transducer for TGF-β, an important bone growth factor. The Smad2-/- mice are lethal and Ghrhrlit/lit mice are dwarf, but both Smad2+/- and Ghrhrlit/+ mice exhibit normal growth. We injected 6-7 weeks old C57BL/6J male mice with ENU (100 mg/kg dose) and bred them with Ghrhrlit/+ and Smad2+/- mice. The F1 mice with Ghrhrlit/+ or Smad2+/- genotype were screened for growth and skeletal phenotypes. An outlier was identified as > 3 SD units different from wild type control (n = 20-30). We screened about 100 F1 mice with Ghrhrlit/+ and Smad2+/- genotypes and identified nine outliers. A backcross established heritability of three mutant lines in multiple generations. Among the phenotypic deviants, we have identified a mutant mouse with 30-40% reduced bone size. The magnitude of the bone size phenotype was amplified by the presence of one copy of the disrupted Ghrhr gene as determined by the 2-way ANOVA (p < 0.02 for interaction). Thus, a new mouse model has been established to identify a gene that interacts with GH signaling to regulate bone size. In addition, the sensitized screen also demonstrated higher recovery of skeletal phenotypes as compared to that obtained in the classical ENU screen in wild type mice. The discovery of mutants in a selected pathway will provide a valuable tool to not only to discover novel genes involved in a particular process but will also prove useful for the elucidation of the biology of that process. © 2007 Elsevier Inc. All rights reserved.
AB - We describe a phenotype-driven mutagenesis screen in which mice carrying a targeted mutation are bred with ENU-treated males in order to provide a sensitized system for detecting dominant modifier mutations. The presence of initial mutation renders the screening system more responsive to subtle changes in modifier genes that would not be penetrant in an otherwise wild type background. We utilized two mutant mouse models: 1) mice carrying a mutation in growth hormone releasing hormone receptor (Ghrhr) (denoted 'lit' allele, Ghrhrlit), which results in GH deficiency; and 2) mice lacking Smad2 gene, a signal transducer for TGF-β, an important bone growth factor. The Smad2-/- mice are lethal and Ghrhrlit/lit mice are dwarf, but both Smad2+/- and Ghrhrlit/+ mice exhibit normal growth. We injected 6-7 weeks old C57BL/6J male mice with ENU (100 mg/kg dose) and bred them with Ghrhrlit/+ and Smad2+/- mice. The F1 mice with Ghrhrlit/+ or Smad2+/- genotype were screened for growth and skeletal phenotypes. An outlier was identified as > 3 SD units different from wild type control (n = 20-30). We screened about 100 F1 mice with Ghrhrlit/+ and Smad2+/- genotypes and identified nine outliers. A backcross established heritability of three mutant lines in multiple generations. Among the phenotypic deviants, we have identified a mutant mouse with 30-40% reduced bone size. The magnitude of the bone size phenotype was amplified by the presence of one copy of the disrupted Ghrhr gene as determined by the 2-way ANOVA (p < 0.02 for interaction). Thus, a new mouse model has been established to identify a gene that interacts with GH signaling to regulate bone size. In addition, the sensitized screen also demonstrated higher recovery of skeletal phenotypes as compared to that obtained in the classical ENU screen in wild type mice. The discovery of mutants in a selected pathway will provide a valuable tool to not only to discover novel genes involved in a particular process but will also prove useful for the elucidation of the biology of that process. © 2007 Elsevier Inc. All rights reserved.
KW - Bone size
KW - Ghrhr
KW - Modifier genetic screen
KW - N-ethyl-N-nitrosourea
KW - Smad2
KW - Mutagenesis/drug effects
KW - Transforming Growth Factor beta/metabolism
KW - Mice, Inbred C57BL
KW - Signal Transduction/genetics
KW - Growth Hormone/metabolism
KW - Male
KW - Mice, Transgenic
KW - Phenotype
KW - Animals
KW - Female
KW - Mice
KW - Drug Evaluation, Preclinical
UR - https://www.scopus.com/pages/publications/37849030722
UR - https://www.scopus.com/pages/publications/37849030722#tab=citedBy
UR - https://www.mendeley.com/catalogue/b55f9c77-318f-3f6b-929d-7c9610d5291c/
U2 - 10.1016/j.bone.2007.10.014
DO - 10.1016/j.bone.2007.10.014
M3 - Article
C2 - 18063435
SN - 8756-3282
VL - 42
SP - 388
EP - 395
JO - Bone
JF - Bone
IS - 2
ER -